Overdose RADAR Act
Summary
What This Bill Does
The bill amends Public Health Service Act Part D to add Section 554 authorizing grants to states, territories, and localities for improved opioid overdose data and surveillance, including postmortem toxicology, data linkage, creates full text of new Section 554 of Public Health Service Act authorizing HHS Secretary to award grants for opioid overdose data improvement including postmortem toxicology testing, data system linkage, electronic, and requires reforms the Office of National Drug Control Policy: sense of Congress that Director should be Cabinet-level, requires ONDCP to document anti-duplication strategies, coordinate with NCHS and NFLIS for national. It relies on grants, appropriations, compliance mandates, and reporting requirements. The main policy areas are Healthcare, Education, Environment, and Trade.
Who Benefits and How
States, territories, and localities could gain revenue opportunities, State and local health departments could gain revenue opportunities, and Naloxone manufacturers (Narcan, Kloxxado) could gain revenue opportunities.
Who Bears the Burden and How
National Drug Control Program agencies would take on compliance duties.
Key Provisions
- Amends Public Health Service Act Part D to add Section 554 authorizing grants to states, territories, and localities for improved opioid overdose data and surveillance, including postmortem toxicology, data linkage...
- Creates full text of new Section 554 of Public Health Service Act authorizing HHS Secretary to award grants for opioid overdose data improvement including postmortem toxicology testing, data system linkage, electronic...
- Requires reforms the Office of National Drug Control Policy: sense of Congress that Director should be Cabinet-level, requires ONDCP to document anti-duplication strategies, coordinate with NCHS and NFLIS for national...
- Amends 21st Century Cures Act state opioid response grants to require assessment of implementation challenges, variations in grant fund use, and sharing of best practices on addressing opioid-related overdoses.
- Directs CDC, in collaboration with the Attorney General, to run a 3-year competitive grant pilot program for municipal wastewater treatment facilities to conduct wastewater analysis for illicit substances like fentanyl...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill amends Public Health Service Act Part D to add Section 554 authorizing grants to states, territories, and localities for improved opioid overdose data and surveillance, including postmortem toxicology, data linkage, creates full text of new Section 554 of Public Health Service Act authorizing HHS Secretary to award grants for opioid overdose data improvement including postmortem toxicology testing, data system linkage, electronic, and requires reforms the Office of National Drug Control Policy: sense of Congress that Director should be Cabinet-level, requires ONDCP to document anti-duplication strategies, coordinate with NCHS and NFLIS for national.
Key Policy Areas
Healthcare, Education, Environment, Trade
Primary Purpose
The bill amends Public Health Service Act Part D to add Section 554 authorizing grants to states, territories, and localities for improved opioid overdose data and surveillance, including postmortem toxicology, data linkage, creates full text of new Section 554 of Public Health Service Act authorizing HHS Secretary to award grants for opioid overdose data improvement including postmortem toxicology testing, data system linkage, electronic, and requires reforms the Office of National Drug Control Policy: sense of Congress that Director should be Cabinet-level, requires ONDCP to document anti-duplication strategies, coordinate with NCHS and NFLIS for national.
Policy Domains
Overdose Data and Surveillance (Sections 2, 554)
Identified Gains
- States, territories, and localities
- State and local health departments
- Naloxone manufacturers (Narcan, Kloxxado)
- Municipal wastewater treatment facilities
- Students and school communities
Identified Costs
- National Drug Control Program agencies
Sponsors
Legislative Progress
In CommitteeMr. Scott of Florida introduced the following bill; which was …
Read twice and referred to the Committee on Health, Education, …
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
National Drug Control Program agencies, Office of National Drug Control Policy, State and local health departments
Positive-direction: State and local health departments, States, territories, and localities
Negative-direction: National Drug Control Program agencies
Communities affected by fentanyl, Drug surveillance researchers, Medical examiner and coroner offices
Public and private schools (elementary and secondary), School districts and administrators, School personnel requiring overdose response training
Naloxone and overdose treatment manufacturers, Naloxone distribution programs, Naloxone manufacturers (Narcan, Kloxxado)
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → Secretary of Health and Human Services
- "doj"
- → Department of Justice
- "hhs"
- → Department of Health and Human Services
- "ondcp_director"
- → Director of ONDCP
- "cdc_director"
- → Director of CDC
- "the_secretary"
- → Secretary of HHS
- "attorney_general"
- → Attorney General
Key Definitions
Terms defined in this bill
Entity with jurisdiction over public and private elementary and secondary schools for purposes of opioid overdose treatment grants
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology